Mack Gill

Mack Gill

Directeur/Membre du Conseil chez ALTIMMUNE, INC.

Fortune : 66 185 $ au 31/05/2026

74 ans
Health Technology
Technology Services
Finance

Profil

John M.
Gill
was the founder of TetraLogic Pharmaceuticals Corp., founded in 2001, where the title held was Director from 2013 to 2014.
Current jobs include Chief Executive Officer at Millennium Information Technologies Ltd. since 2013, Independent Director at Altimmune, Inc. since 2004, and Chief Operating Officer at Torstone Technology Ltd. Former jobs include President, Chief Executive Officer & Director at PharmAthene, Inc. from 2015 to 2017, Chief Financial Officer, Director & Executive VP at 3-Dimensional Pharmaceuticals, Inc., Director at PharmAthene, Inc. in 2007, Director at Theraclone Sciences, Inc., Director at The Biotechnology Greenhouse Corp.
of Southeastern PA, Director at Ben Franklin Technology Partners, SVP-Corporate Development & Strategy at FIS Capital Markets US LLC (Pennsylvania), President at GSK Equity Investments Ltd, Principal at US Department of Defense (District of Columbia) from 1971 to 1973, Chief Operating Officer at Smithkline & French Laboratories US, Inc., President-Global Technology at SunGard Financial Systems, Chief Operating Officer at Nova Pharmaceutical Corp., VP-Research & Development Operations at GlaxoSmithKline LLC, and President at Sungard Global Services France SA in 2011.
Education includes undergraduate degree from Rutgers State University of New Jersey in 1975, graduate degree from Yale University, and undergraduate degree from the University of British Columbia.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
01/05/2026 21 700 ( 0,01% ) 66 185 $ 31/05/2026

Postes actifs de Mack Gill

SociétésPosteDébut
ALTIMMUNE, INC. Directeur/Membre du Conseil 01/08/2004
Directeur Général 23/05/2013
Directeur des opérations -

Anciens postes connus de Mack Gill

SociétésPosteFin
Directeur Général 01/05/2017
TETRALOGIC PHARMACEUTICALS CORPORATION Fondateur 29/01/2014
President 01/03/2011
Directeur/Membre du Conseil 30/04/2008
Directeur/Membre du Conseil 03/08/2007
Voir l'expérience en détail de Mack Gill

Formation de Mack Gill

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

67

Relations au 1er degré

21

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées21

Technology Services

Health Technology

Health Technology

Health Technology

Health Technology

Technology Services

Finance

Finance

Consumer Services

Consumer Services

Consumer Services

Government

Finance

Health Technology

Smithkline & French Laboratories US, Inc.

Technology Services

Nova Pharmaceutical Corp.

Health Technology

Technology Services

Technology Services

Health Technology

- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT